PharmiWeb33m
InTheZone Labs Progresses Towards Amazon Listing, Expands Affiliate Program, and Shares Promising Phase One Testing Updates
Nitches, Inc. (OTC:NICH) is excited to announce significant strides for its flagship brand, InTheZone Labs. As the year winds down, the company continues to pave the way for its products to redefine ...
PharmiWeb1h
Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy
The designation is a result of UNEEG's strong focus on developing novel disease management support tools with ...
PharmiWeb1h
MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences
DUBAI, UAE / ACCESSWIRE / November 25, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), operating as M2Bio Sciences, is a pioneering biotechnology company dedicated to advancing ...
PharmiWeb1h
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / November 25, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the ...
PharmiWeb2h
Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies
New Members Strengthen Board of Directors CHAPEL HILL, NC / ACCESSWIRE / November 25, 2024 / Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, ...
PharmiWeb2h
Quantum BioPharma Previously Known as FSD Pharma
TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up ...
PharmiWeb2h
Acreage Provides Update on Corporate Transactions
NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Acreage Holdings, Inc. ("Acreage" or the "Company") (CSE:ACRG.A.U, ACRG.B.U)(OTCQX:ACRHF, ACRDF), a vertically integrated, multi-state operator of ...
PharmiWeb3h
Moderna to Present at Upcoming Conferences in December 2024
CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:7th Annual Evercore ISI HealthCONx ...
PharmiWeb4h
SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry
Mergers & AcquisitionsSYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry 25.11.2024 / 11:39 CET/CESTThe issuer is solely responsible for the content of this ...
PharmiWeb7h
BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity
VANCOUVER, BC / ACCESSWIRE / November 25, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce the expansion of its next-generation ...
PharmiWeb3d
Eckert & Ziegler raises its forecast for the current financial year once again
Change in ForecastEckert & Ziegler raises its forecast for the current financial year once again22-Nov-2024 / 15:27 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation ...
PharmiWeb3d
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer ...